Account
Articles
07.09.2023
Prescription Price Puzzles: The Sky-High Cost of O...

This article explores the significant disparities between the US and Europe regarding orphan drugs a...

Read more
Insider Insights
29.08.2023
CMS announces first 10 drugs to undergo price nego...

The Centers for Medicare and Medicaid Services has unveiled a list of 10 drugs to undergo Medicare p...

Read more
Newsletter
02.08.2023
PMA Insights: Week 29

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
24.07.2023
Johnson & Johnson sue the US government

J&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde...

Read more
Articles
09.06.2023
What is a fair value for oncology combination pric...

We explore the issues faced by manufacturers and payers for oncology combination pricing and the pot...

Read more
Newsletter
07.06.2023
PMA Insights: Week 23

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Case Study
26.04.2023
Development of an EU go-to-market access plan

Our client is developing best-in-class antibodies to neutralise coronaviruses. Our client wanted to...

Read more
Case Study
26.04.2023
Gaining payer insights

Our client required focused payer value messages for their PUMA product as payers were not recognisi...

Read more
Case Study
26.04.2023
Gaining payer insights

Our client required focused payer value messages for their PUMA product as payers were not recognizi...

Read more
Case Study
26.04.2023
Developing a pharmacy submission pack

Our client wanted to broaden access and funding for their reproduction biosimilar in the UK. However...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.